SUPPLEMENT

Q1 2026 — Financial statement information

Q1 2026PDF · 11 pages218 KB
Three months ended
March 31,
2026 2025
Net sales $ 6,030 $ 5,954
Operating expenses
Cost of sales 3,574 3,478
Selling, general and administrative expenses 744 945
Research, development and related expenses 308 285
Loss on business divestitures 7 —
Total operating expenses 4,633 4,708
Operating income 1,397 1,246
Other expense (income), net 519 (139)
Income before income taxes 878 1,385
Provision for income taxes 221 265
Income of consolidated group 657 1,120
Income from unconsolidated subsidiaries, net of taxes 2 2
Net income including noncontrolling interest 659 1,122
Less: net income attributable to noncontrolling interest 6 6
Net income attributable to 3M $ 653 $ 1,116
Earnings per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 529.1 543.8
Earnings per share — basic $ 1.23 $ 2.05
Weighted average 3M common shares outstanding — diluted 532.8 547.7
Earnings per share — diluted $ 1.23 $ 2.04
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 11 --

March 31, 2026 December 31, 2025
Assets
Current assets
Cash and cash equivalents $ 3,729 $ 5,235
Marketable securities 420 698
Accounts receivable – net 3,754 3,533
Inventories 3,690 3,661
Prepaids 407 391
Assets held for sale 49 46
Other current assets 2,344 2,823
Total current assets 14,393 16,387
Property, plant and equipment – net 6,960 7,101
Goodwill and intangible assets – net 7,462 7,522
Other assets 6,621 6,723
Total assets $ 35,436 $ 37,733
Liabilities and equity
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,650 $ 1,670
Accounts payable 2,786 2,702
Accrued payroll 420 718
Liabilities held for sale 56 55
Other current liabilities 4,120 4,450
Total current liabilities 9,032 9,595
Long-term debt 10,906 10,932
Other liabilities 12,187 12,459
Total liabilities 32,125 32,986
Total equity 3,311 4,747
Shares outstanding
March 31, 2026: 521,567,261
December 31, 2025: 530,279,131
Total liabilities and equity $ 35,436 $ 37,733
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 11 --

Three months ended March 31,
2026 2025
Net cash provided by (used in) operating activities $ 574 $ (79)
Cash flows from investing activities:
Purchases of property, plant and equipment (225) (236)
Purchases and proceeds from sale or maturities of marketable securities and
investments – net 281 1,441
Other investing activities 4 15
Net cash provided by (used in) investing activities 60 1,220
Cash flows from financing activities:
Change in debt – net — 349
Purchases of treasury stock and dividends paid to shareholders (2,411) (1,670)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 302 905
Other financing activities (15) (6)
Net cash provided by (used in) financing activities (2,124) (422)
Effect of exchange rate changes on cash and cash equivalents (13) 7
Net increase (decrease) in cash and cash equivalents, including cash classified within
assets held for sale (1,503) 726
Less: net increase (decrease) in cash classified within assets held for sale 3 —
Net increase (decrease) in cash and cash equivalents (1,506) 726
Cash and cash equivalents at beginning of year 5,235 5,600
Cash and cash equivalents at end of period $ 3,729 $ 6,326
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 11 --

Three months ended March 31, 2026
By reportable business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 3.2 % — % 3.6 % 6.8 %
Transportation and Electronics (0.3) (0.3) 2.4 1.8
Consumer (1.3) — 1.9 0.6
Total reportable business segments 1.2 (0.1) 2.9 4.0
Total Company (1.4) (0.1) 2.8 1.3
By geographic area
Americas (2.6) % (0.2) % 1.1 % (1.7) %
China 4.4 — 4.2 8.6
Other Asia 0.3 — (0.4) (0.1)
Europe, Middle East and Africa (3.2) — 9.9 6.7
2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition
and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months
post-transaction.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS2
(Unaudited)
4

-- 4 of 11 --

3M discloses business segment operating income as its measure of segment profit, which is reconciled to both total 3M
operating income and income before taxes. This measure excludes certain expenses and income not allocated to business
segments (as described below in “Corporate”).
Effective in the first quarter of 2026, the measure of segment operating performance and segment composition used by the
3M’s chief operating decision maker (CODM) changed. As a result, 3M’s disclosed measure of segment profit and other
segment-related amounts were updated to align with these changes. The financial information presented herein reflects the
impact of these changes for all periods presented. These include:
• Reflecting manufactured PFAS products activity and net costs for respirator mask/asbestos litigation special
items within Corporate: Previously, these special items were included in the Transportation and Electronics segment
and Safety and Industrial segment, respectively. Elements related to manufactured PFAS products activity are now
included in Corporate, with sales and income (loss) reflected as a special item. Net costs related to respirator mask/
asbestos are now also reflected in Corporate, within the net costs for significant litigation Corporate special item.
Three months ended
March 31,
Net sales (millions) 2026 2025
Abrasives $ 349 $ 317
Automotive Aftermarket 304 290
Electrical Markets 356 325
Industrial Adhesives and Tapes 604 543
Industrial Specialties Division 286 288
Personal Safety 912 850
Roofing Granules 119 132
Total Safety and Industrial business segment 2,930 2,745
Advanced Materials 147 143
Automotive and Aerospace 484 475
Commercial Branding and Transportation 640 616
Electronics 577 582
Total Transportation and Electronics business segment 1,848 1,816
Consumer Safety and Well-Being 278 274
Home and Auto Care 328 299
Home Improvement 311 326
Packaging and Expression 214 225
Total Consumer business segment 1,131 1,124
Total reportable business segments 5,909 5,685
Corporate 121 269
Total company $ 6,030 $ 5,954
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 11 --

Operating income (millions)
Safety and Industrial $ 776 $ 699
Transportation and Electronics 399 390
Consumer 217 219
Total reportable business segments 1,392 1,308
Corporate
Corporate-level (expense) income 34 50
Corporate special items:
Net (costs) benefit from significant litigation 170 (74)
(Loss) gain on business divestitures (7) —
Manufactured PFAS products (126) (38)
Transformation costs (66) —
Total Corporate 5 (62)
Total Company operating income 1,397 1,246
Other expense/(income), net 519 (139)
Income before income taxes $ 878 $ 1,385
Corporate
Outside of 3M's reportable segments, 3M has Corporate which is not a reportable business segment as it does not meet the
segment reporting criteria. Because Corporate includes a variety of miscellaneous items, it is subject to fluctuation on a
quarterly and annual basis.
Corporate operating income (loss) includes:
• Corporate-level (expense) income includes:
◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs
that 3M may choose not to allocate directly to its business segments,
◦ commercial activity with Solventum following its April 2024 spin-off from 3M, as well as certain operations
of 3M’s former health care business segment that were retained by 3M, and
◦ transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to Solventum.
• Corporate special items include, for the periods presented:
◦ net costs for significant litigation impacting operating income (loss),
◦ manufactured PFAS products activity
◦ (loss) gain on business divestitures,
◦ transformation program restructuring and related charges.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 11 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered in evaluating and managing operations; useful in
understanding underlying business performance, provides additional
transparency to special items
• Operating income (loss) and operating income
(loss) margin (and expansion)
• Income before taxes
• Provision for income taxes and effective tax rate
• Net income
• EPS
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7

-- 7 of 11 --

Certain amounts adjusted for special items (non-GAAP measures):
(dollars in millions, except per share amounts)
Three months ended March 31, 2025
Net sales
Operating
income
Operating
income
margin
Income
before
taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
Total Company GAAP amounts $ 5,954 $ 1,246 20.9 % $ 1,385 $ 265 19.1 % $ 1,116 $ 2.04
Corporate GAAP amounts 269 (62)
Adjustments for special items:
Net costs for significant litigation — 74 224 (2) 226 0.41
Manufactured PFAS products (174) 38 38 9 29 0.06
Solventum ownership - change in value — — (343) — (343) (0.63)
Total special items (174) 112 (81) 7 (88) (0.16)
Total Company adjusted amounts (non-GAAP
measures)3 $ 5,780 $ 1,358 23.5 % $ 1,304 $ 272 20.9 % $ 1,028 $ 1.88
Corporate adjusted amounts (non-GAAP
measures)3 $ 95 $ 50
Three months ended March 31, 2026
Net
sales
Sales
change
Operating
income
Operating
income
margin
Operating
income
margin
expansion
Income
before
taxes
Provision
for
income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Total Company GAAP amounts $ 6,030 1.3 % $ 1,397 23.2 % 230 bps $ 878 $ 221 25.2 % $ 653 $ 1.23 (40) %
Corporate GAAP amounts $ 121 $ 5
Adjustments for special items:
Net costs (benefit) from
significant litigation — (170) (45) (25) (20) (0.04)
Loss on business divestitures — 7 7 1 6 0.01
Manufactured PFAS products (27) 126 126 31 95 0.18
Solventum ownership - change in
value — — 356 — 356 0.67
Transformation costs — 66 66 16 50 0.09
Total special items (27) 29 510 23 487 0.91
Adjusted amounts (non-GAAP
measures)3 $ 6,003 3.9 % $ 1,426 23.8 % 30 bps $ 1,388 $ 244 17.5 % $ 1,140 $ 2.14 14 %
Corporate adjusted amounts (non-
GAAP measures)3 $ 94 $ 34
3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
2026 forecast
2026 adjusted operating income margin expansion (non-GAAP measure)3,4 70 bps to 80 bps
2026 adjusted earnings per share (non-GAAP measure)3,4 $8.50 to $8.70
2026 adjusted effective tax rate (non-GAAP measure)3,4 ~20%
43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum
ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all
of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M
believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M
believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of
potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction.
Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8

-- 8 of 11 --

Three months ended March 31, 2026
Sales change2 Organic sales Divestitures Translation Total sales
change
Total company (1.4) % (0.1) % 2.8 % 1.3 %
Remove manufactured PFAS products special item impact 2.6 — — 2.6
Adjusted total company (non-GAAP measures)3 1.2 % (0.1) % 2.8 % 3.9 %
By geographic area
Americas (2.6) % (0.2) % 1.1 % (1.7) %
Remove manufactured PFAS products special item impact 2.7 — — 2.7
Adjusted Americas (non-GAAP measures)3 0.1 % (0.2) % 1.1 % 1.0 %
China 4.4 % — % 4.2 % 8.6 %
Remove manufactured PFAS products special item impact (0.4) — — (0.4)
Adjusted China (non-GAAP measures)3 4.0 % — % 4.2 % 8.2 %
Other Asia 0.3 % — % (0.4) % (0.1) %
Remove manufactured PFAS products special item impact 4.3 — — 4.3
Adjusted Other Asia (non-GAAP measures)3 4.6 % — % (0.4) % 4.2 %
Europe, Middle East & Africa (3.2) % — % 9.9 % 6.7 %
Remove manufactured PFAS products special item impact 2.5 — 0.2 2.7
Adjusted Europe, Middle East & Africa (non-GAAP measures)3 (0.7) % — % 10.1 % 9.4 %
By particular country
United States (3.2) % (0.1) % — % (3.3) %
Remove manufactured PFAS products special item impact 3.2 (0.1) — 3.1
Adjusted United States (non-GAAP measures)3 — % (0.2) % — % (0.2) %
2026 forecast
Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company4 ~3% — % — % ~1% ~4%
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
March 31,
Major GAAP cash flow categories (dollars in millions) 2026 2025
Net cash provided by (used in) operating activities $ 574 $ (79)
Net cash provided by (used in) investing activities 60 1,220
Net cash provided by (used in) financing activities (2,124) (422)
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9

-- 9 of 11 --

Three months ended
March 31,
Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2026 2025
Net cash provided by (used in) operating activities $ 574 $ (79)
Adjustments for special items:
Net costs/(recoveries) for significant litigation after-tax payment impacts 109 787
Divestiture costs after-tax payment impacts — 16
Transformation actions after-tax payment impacts 32 —
Manufactured PFAS products after-tax payment impacts 51 (7)
Total adjustments for special items 192 796
Adjusted net cash provided by (used in) operating activities (non-GAAP
measure)5
$ 766 $ 717
Purchases of property, plant and equipment (PPE) (225) (236)
Manufactured PFAS products impact - removing related purchases of PPE — 8
Adjusted purchases of PPE (non-GAAP measure)5 $ (225) $ (228)
Adjusted free cash flow (non-GAAP measure)5 $ 541 $ 489
Adjusted net income attributable to 3M $ 1,140 $ 1,028
Adjusted free cash flow conversion (non-GAAP measure)5 47 % 48 %
53M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special
items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of
property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products
activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE.
Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are
reflected net of applicable tax. The cash tax impact is determined by the amount, timing, and applicable tax rates for the actual cash tax
payments, which may differ from the timing of the related pre-tax cash payments or underlying transactions. 3M defines adjusted free cash
flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items (used for adjusted free cash
flow conversion calculation).
(Dollars in billions) 2026 forecast
Net cash provided by (used in) operating activities $5.6 to $5.8
Adjustments for special items4 —
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4,5 $5.6 to $5.8
Purchase of property, plant and equipment (PPE) ~1.1
Adjusted free cash flow (non-GAAP measure)4,5 $4.6 to $4.8
Net income attributable to 3M $4.6 to $4.7
Adjustments for special items4 —
Adjusted net income attributable to 3M (non-GAAP measure)3,4 $4.6 to $4.7
Adjusted free cash flow conversion (non-GAAP measure)4,5 >100%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
10

-- 10 of 11 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the
associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible
Income ("FDII"), Net Controlled Foreign Corporation Tested Income ("NCTI"), foreign tax credits, and tax costs of
repatriation. 3M does not consider the elements of the net costs associated with these matters to be normal, operating
expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and
regulatory environment. In the first quarter of 2026 and 2025, 3M reflected net pre-tax cash (receipts)/payments of $102
million and $806 million, respectively, related to net costs for significant litigation.
Gain/loss on business divestitures:
• In the third quarter of 2025, 3M classified a business as held for sale. In the first quarter of 2026, 3M reflected an
adjustment to carrying it at its selling price less cost to sell.
Manufactured PFAS products:
• These amounts relate to sales and income (loss) and associated activity regarding manufactured PFAS products that 3M
exited by the end of 2025. Income does not contemplate impacts on non-operating items such as net interest income/
expense and the non-service cost components portion of defined benefit plan net periodic benefit costs. Relative to the
impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are
based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and
timing of associated payments.
Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
Transformation costs:
• These represent net costs associated with 3M's transformation program, intended as a structural redesign of longer-term
manufacturing, distribution, and business process services and locations. Accordingly, 3M does not consider the nature or
effect of this program to be normal, operating expenses related to the Company’s ongoing operations, revenue generating
activities, and day-to-day business strategy. Net costs include restructuring and other related items such as site closure,
sale, moving and set-up, accelerated depreciation, and program management. In the first quarter of 2026, 3M made pre-
tax cash payments of $32 million associated with transformation costs.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
11

-- 11 of 11 --